These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 8162239
21. Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Circulation; 1995 Feb 01; 91(3):831-7. PubMed ID: 7828312 [Abstract] [Full Text] [Related]
22. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians. Nagi DK, Tracy R, Pratley R. Metabolism; 1996 Oct 01; 45(10):1243-7. PubMed ID: 8843179 [Abstract] [Full Text] [Related]
24. Angiotensinogen gene polymorphism is associated with insulin resistance in nondiabetic men with or without coronary heart disease. Sheu WH, Lee WJ, Jeng CY, Young MS, Ding YA, Chen YT. Am Heart J; 1998 Jul 01; 136(1):125-31. PubMed ID: 9665229 [Abstract] [Full Text] [Related]
25. Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Paolisso G, De Riu S, Marrazzo G, Verza M, Varricchio M, D'Onofrio F. Metabolism; 1991 Sep 01; 40(9):972-7. PubMed ID: 1895963 [Abstract] [Full Text] [Related]
26. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in patients with coronary artery disease independent of obesity. Psyrogiannis AJ, Alexopoulos DK, Kyriazopoulou VE, Vagenakis AG. Angiology; 1998 Aug 01; 49(8):607-12. PubMed ID: 9717889 [Abstract] [Full Text] [Related]
27. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Felber JP, Ferrannini E, Golay A, Meyer HU, Theibaud D, Curchod B, Maeder E, Jequier E, DeFronzo RA. Diabetes; 1987 Nov 01; 36(11):1341-50. PubMed ID: 3311856 [Abstract] [Full Text] [Related]
28. Coronary heart disease mortality risk: plasma insulin level is a more sensitive marker than hypertension or abnormal glucose tolerance in overweight males. The Paris Prospective Study. Fontbonne A, Tchobroutsky G, Eschwege E, Richards JL, Claude JR, Rosselin GE. Int J Obes; 1988 Nov 01; 12(6):557-65. PubMed ID: 3069769 [Abstract] [Full Text] [Related]
35. Fasting insulin levels independently associated with coronary heart disease in non-diabetic Turkish men and women. Onat A, Ceyhan K, Sansoy V, Basar O, Erer B, Uysal O, Hergenç G. Int J Cardiol; 2002 Nov 01; 86(1):61-9. PubMed ID: 12243850 [Abstract] [Full Text] [Related]
36. Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). Rubins HB, Robins SJ, Collins D, Nelson DB, Elam MB, Schaefer EJ, Faas FH, Anderson JW. Arch Intern Med; 2002 Nov 01; 162(22):2597-604. PubMed ID: 12456232 [Abstract] [Full Text] [Related]
37. The effects of superphysiologic hyperinsulinemia on glucose and lipid metabolism in glucose-tolerant offspring of patients with non-insulin-dependent diabetes mellitus (NIDDM). Osei K. Diabetes Res Clin Pract; 1992 Sep 01; 17(3):169-82. PubMed ID: 1425156 [Abstract] [Full Text] [Related]
40. Metabolic defects in persistent impaired glucose tolerance are related to the family history of non-insulin-dependent diabetes mellitus. Niskanen L, Sarlund H, Laakso M. Metabolism; 1995 Aug 01; 44(8):1099-104. PubMed ID: 7637652 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]